News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement Shelley Wood November 14, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Conference News TCT 2016 Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients Todd Neale November 02, 2016
News Conference News PCR London Valves 2016 TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients Shelley Wood September 20, 2016
News Conference News PCR London Valves 2016 Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies Shelley Wood September 19, 2016
News Conference News TVT 2016 Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance Shelley Wood June 20, 2016
News Conference News TVT 2016 Teenage TAVR: Should Practice Forge on While Guidelines Grow Up? Michael O'Riordan June 20, 2016
News Conference News TVT 2016 Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY Michael O'Riordan June 18, 2016
News Conference News TVT 2016 Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes Michael O'Riordan June 16, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Conference News EuroPCR 2016 Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up Shelley Wood May 20, 2016
News Conference News EuroPCR 2016 No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests Michael O'Riordan May 19, 2016
News Conference News EuroPCR 2016 As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease Shelley Wood May 18, 2016
News Conference News EuroPCR 2016 ‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR Yael L. Maxwell May 18, 2016
News Conference News EuroPCR 2016 WIN-TAVI Registry Homes in on TAVR Outcomes Unique to Female Patients Caitlin E. Cox May 17, 2016
News Conference News EuroPCR 2016 EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’ Shelley Wood May 16, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2016 Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial Yael L. Maxwell April 03, 2016